| Azerbaijan | Turkey | Austria | |
| Therapeutic Apheresis | - | from $1,350 | - |
| Selective Apheresis | - | from $1,550 | - |
| Plasmapheresis | - | from $1,200 | from $2,000 |
| Plasma Exchange | - | from $3,900 | - |
| Lymphoma chemotherapy | - | from $3,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hematology Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hematology Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hematology Oncology treatment journey.
Dr. Aydogdu specializes in early detection of pediatric cancers, focusing on improving outcomes for young patients at Liv Bona Dea Hospital Baku.
Written by Anna Leonova
Written by Anna Leonova
Written by Halina Shubala
Patients receiving hematology-oncology treatments in Azerbaijan may experience short-term side effects like hair loss and fatigue. Long-term risks include peripheral neuropathy and cognitive changes. Accredited centers like Liv Bona Dea Hospital Baku or the National Center of Oncology provide multidisciplinary support to manage these concerns.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves 200,000 patients yearly and was ranked by Bookimed for excellence in blood disorders and cancer treatment in 2019. This high patient volume allows specialist doctors like Dr. Selime Aydogdu and Tural Pashayev to refine supportive care protocols for complex conditions like leukemia and myeloma. Patients should prioritize JCI-accredited facilities in Baku to ensure international safety standards for managing treatment toxicity.
Patient Consensus: Patients note that fatigue is often more intense than expected and not easily relieved by rest. They also emphasize that neuropathy and memory issues can persist long after treatment ends, making early discussions about these risks essential.
Liv Bona Dea Hospital Baku and the National Center of Oncology are the leading facilities for haematology-oncology in Azerbaijan. These centres provide JCI-accredited care and integrated diagnostic laboratories. They specialise in treating blood cancers like leukaemia and lymphoma using immunotherapy and bone marrow transplantation.
Bookimed Expert Insight: Data shows Liv Bona Dea Hospital Baku consistently ranks as a top choice. While the National Center of Oncology has more beds, Liv Bona Dea prioritises shorter waiting times. This makes them more accessible for those travelling from abroad for urgent chemotherapy or biopsies.
Patient Consensus: Patients in Azerbaijan value hospitals that combine pathology, chemotherapy, and transfusion services. They often note that having specialist haematologists ensures clearer diagnostic staging and transparent treatment options.
Azerbaijan provides oncological care featuring bone marrow transplantation, immunotherapy, and targeted molecular therapies. JCI-accredited facilities in Baku, such as Liv Bona Dea Hospital Baku, use global protocols. Treatments include TrueBeam radiotherapy, HIPEC for abdominal cancers, and precision medicine for complex blood disorders.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku serves over 200,000 patients annually. It holds specific 2019 rankings for excellence in cancer and blood disorders. This high patient volume allows the facility to maintain 219 beds and 20 specialised departments. Australian patients can expect care that includes genetic tumour profiling and molecular testing.
Patient Consensus: Patients suggest confirming local diagnostic capacity and requesting English medical reports before travel. Experience shows that Baku facilities effectively coordinate complex multi-cycle regimens. They also provide dedicated international service desks.
Recommended haematologist-oncologists in Baku for international consultations include Dr Tural Pashayev and Dr Selime Aydogdu. They practise at the JCI-accredited Liv Bona Dea Hospital. These specialists provide care for adult and paediatric blood disorders. They use modern protocols for bone marrow transplants and cell therapy.
Bookimed Expert Insight: Baku has become a regional hub for haematology-oncology. Liv Bona Dea Hospital serves over 200,000 patients annually. In 2019, it received top rankings for blood disorder treatment. This high patient volume often means the medical teams have extensive experience. They handle complex cases like bone marrow failure and rare metabolic blood diseases.
Patient Consensus: Patients find the international support teams in Azerbaijan helpful. They appreciate that major facilities coordinate digital scan uploads. These teams also handle translations for overseas medical records.
Azerbaijan provides specialised treatment for blood disorders through dedicated centres and specialist clinics in Baku. Facilities like Liv Bona Dea Hospital Baku offer bone marrow transplantation, factor therapy, and iron chelation. The country manages these conditions through national healthcare programmes and regional haematology networks.
Bookimed Expert Insight: Liv Bona Dea Hospital Baku stands out for international patients. It holds JCI accreditation. Bookimed patients ranked it as a top centre for blood disorder treatment. Public centres handle high local volume. However, this private facility integrates Turkish Medical Association standards. This makes it a preferred choice for those seeking private rooms.
Patient Consensus: Patients recommend verifying that hospitals have dedicated haematology services before travel. Those managing rare disorders emphasise confirming access to clotting factors. They also suggest coordinating care with tertiary centres in Baku.
Medical tourism for oncology in Baku is a rapidly growing regional sector. The city is a hub for haematology-oncology. It serves many patients from Central Asia and the CIS. Facilities like Liv Bona Dea Hospital Baku use Turkish medical partnerships and maintain JCI-accredited standards.
Bookimed Expert Insight: Baku has transitioned from a patient source to a regional treatment destination. Liv Bona Dea Hospital Baku now treats 200,000 patients annually across 20 departments. This volume allows the facility to provide diverse specialisations within a single centre. These range from adult haematology to paediatric cell therapy.
Patient Consensus: Patients value having access to Turkish clinical protocols in Azerbaijan. Large private hospitals in Baku are praised for their multidisciplinary approach to blood disorders and complex cancers.